Table 2.
Strongest Predictors of Osteoprotegerin Levels at Baseline and 1 Month
| Background Characteristic | Baseline | 1 Month | ||||
|---|---|---|---|---|---|---|
| N | P Value | N | P Value | |||
| Ticagrelor | 1509 | 0.999 (0.978–1.021) | 0.9536 | |||
| Age, 10‐y increase | 4406 | 1.096 (1.081–1.111) | <0.0001 | 3035 | 1.102 (1.087–1.116) | <0.0001 |
| Female sex | 1319 | 1.088 (1.059–1.117) | <0.0001 | 894 | 1.072 (1.045–1.100) | <0.0001 |
| STE‐ACS | 2052 | 1.104 (1.075–1.134) | <0.0001 | 1471 | 0.972 (0.948–0.996) | 0.0236 |
| Hs‐TnT, 10% increase | 4406 | 1.002 (1.001–1.002) | <0.0001 | 3035 | 1.000 (0.998–1.002) | 0.9237 |
| GDF‐15, 10% increase | 4406 | 1.023 (1.020–1.026) | <0.0001 | 3035 | 1.013 (1.010–1.016) | <0.0001 |
| Cystatin‐C, 10% increase | 4406 | 0.991 (0.987–0.995) | <0.0001 | 3035 | 1.003 (0.999–1.008) | 0.1612 |
| Hs‐CRP, 10% increase | 4406 | 1.004 (1.003–1.005) | <0.0001 | 3035 | 1.003 (1.002–1.004) | <0.0001 |
| WBC count, 10% increase | 4406 | 1.011 (1.007–1.015) | <0.0001 | 3035 | 1.007 (1.002–1.011) | 0.0022 |
GDF‐15 indicates growth differentiation factor‐15; hs‐CRP, high‐sensitivity C‐reactive protein; hs‐TnT, high‐sensitivity troponin T; STE‐ACS, ST‐segment–elevation acute coronary syndrome; and WBC, white blood cell.